ArticleNeuro-oncology advances

The impact of timing of temozolomide chemoradiotherapy for newly diagnosed glioblastoma on patient overall survival: A multicenter retrospective study.

Arthur C K Lau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.